Table 4.
Linear regression of baseline patient parameters to number of myocardial segments with improved function at follow-up study
| Number of myocardial segments (per-patient) with improved function | |||
|---|---|---|---|
| Univariate | Multivariate | Beta | |
| P-Value | P-Value | ||
| Age | 0.11 | ||
| Sex | 0.99 | ||
| Diabetes Mellitus | 0.57 | ||
| Hypertension | 0.69 | ||
| Smoker | 0.53 | ||
| Time from onset of CP to reperfusion | 0.93 | ||
| Killip Class I | 0.76 | ||
| Killip Class II | 0.85 | ||
| Killip Class III-IV | 0.79 | ||
| Left main stem disease | 0.14 | ||
| 1-vessel disease | 0.48 | ||
| 2-vessel disease | 0.67 | ||
| 3-vessel disease | 0.87 | ||
| TIMI flow pre-intervention | 0.47 | ||
| TIMI flow post intervention | 0.47 | ||
| LVEDV | 0.74 | ||
| LVESV | 0.76 | ||
| LV Mass | 0.39 | ||
| LV ejection fraction | 0.51 | ||
| Stroke volume | 0.43 | ||
| Infarct size | 0.57 | ||
| Area at risk (AAR) | 0.18 | ||
| Acute non-infarcted normal myocardial ECV | 0.89 | ||
| Acute AAR ECV | 0.05 | 0.32 | |
| Acute Infarct ECV | 0.04 | 0.037 | 0.29 |